AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Solesence, Inc. Common Stock
XNAS · usd
SIC 2844 · PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
FIGI BBG001S6M0L5
0.80▼ 0.06 (-6.58%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
0.86
Day's Range
0.80 – 0.83
52-Week Range
0.61 – 3.80
Volume
16.7K
Avg Volume
29.2K
Share Statistics
Shares Outstanding
Employees
115
Exchange
XNAS
Listed
1997-11-26
Share count as of August 19, 2026

Solesence, Inc. Common Stock (SLSN) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Solesence, Inc. Common Stock (SLSN)
What is Solesence, Inc. Common Stock's Market Cap?
Solesence, Inc. Common Stock's Market Cap is $56.5M, based on as-reported figures from SEC (XBRL) filings.
What is Solesence, Inc. Common Stock's Price / Sales?
Solesence, Inc. Common Stock's Price / Sales is 1.0×, based on as-reported figures from SEC (XBRL) filings.
What is Solesence, Inc. Common Stock's Revenue (TTM)?
Solesence, Inc. Common Stock's Revenue (TTM) is $55.4M, based on as-reported figures from SEC (XBRL) filings.
What is Solesence, Inc. Common Stock's Net Income (TTM)?
Solesence, Inc. Common Stock's Net Income (TTM) is -$2.9M, based on as-reported figures from SEC (XBRL) filings.
What is Solesence, Inc. Common Stock's EBITDA?
Solesence, Inc. Common Stock's EBITDA is -$921.0K, based on as-reported figures from SEC (XBRL) filings.
What is Solesence, Inc. Common Stock's Diluted EPS (TTM)?
Solesence, Inc. Common Stock's Diluted EPS (TTM) is -0.04, based on as-reported figures from SEC (XBRL) filings.
What is Solesence, Inc. Common Stock's EBITDA Margin?
Solesence, Inc. Common Stock's EBITDA Margin is -1.7%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · SLSNAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Revenue—
YoY growth-24.7%—-0.7%-13.5%
Operating expense:
Cost of Revenue
Gross profit
% of revenue31.0%—27.5%23.1%
Research and Development Expense
Selling, General and Administrative Expense
Net income (loss) from operations
% of revenue0.8%—1.5%-5.4%
Net income (loss)
% of revenue-1.0%—1.3%-7.7%
Earnings Per Share (Basic)
Earnings Per Share (Diluted)